Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
USE OF A COMPOUND HAVING TWO GOLD (I) ATOMS EACH COVALENTLY BONDED TO A CARBON ATOM IN A COVALENT LINK CONNECTING THE TWO GOLD (I) ATOMS FOR THE TREATMENT OF CANCER
Document Type and Number:
WIPO Patent Application WO2005058421
Kind Code:
A3
Abstract:
The invention relates to the treatment of cancers, in particular, cancers that are resistant to platinum based chemotherapeutic agents. A pharmaceutical composition for the treatment of cancer comprising an effective amount of a compound having two gold(I) atoms each covalently bonded to a carbon atom in a covalent link connecting the two gold(I) atoms and a pharmaceutically acceptable excipient.

Inventors:
FLOWER KEVIN (GB)
MCGOWN ALAN (GB)
Application Number:
PCT/GB2004/005440
Publication Date:
August 18, 2005
Filing Date:
December 20, 2004
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV SALFORD (GB)
UMIST VENTURES LTD (GB)
PATERSON INST FOR CANCER RES (GB)
FLOWER KEVIN (GB)
MCGOWN ALAN (GB)
International Classes:
A61K31/66; (IPC1-7): A61P35/00; A61K31/66
Foreign References:
EP0189306A21986-07-30
Other References:
BARNARD, PETER J. ET AL: "Mitochondrial permeability transition induced by dinuclear gold(I)-carbene complexes: potential new antimitochondrial antitumour agents", JOURNAL OF INORGANIC BIOCHEMISTRY , 98(10), 1642-1647 CODEN: JIBIDJ; ISSN: 0162-0134, 2004, XP002329454
SCHMIDBAUR H ET AL: "SOME GOLD I COMPLEXES OF PHOSPHORUS YLIDES AND THEIR EFFECT IN GOLD THERAPY WITH THE ADJUVANT ARTHRITIS MODEL", ZEITSCHRIFT FUER NATURFORSCHUNG TEIL B ANORGANISCHE CHEMIE ORGANISCHE CHEMIE, vol. 33, no. 11, 1978, pages 1325 - 1329, XP009048242, ISSN: 0340-5087
ROZENBERG, V. I. ET AL: "Mono(tin)- and bis(gold)-metalated covalently bonded .sigma.-aryl derivatives in the [2.2]paracyclophane series", METALLOORGANICHESKAYA KHIMIYA , 4(3), 686-8 CODEN: MEKHEX; ISSN: 0235-0114, 1991, XP009048161
CAGNOLI, MONICA ET AL: "Synthesis and biological activity of gold and tin compounds in ovarian cancer cells", ANTI-CANCER DRUGS , 9(7), 603-610 CODEN: ANTDEV; ISSN: 0959-4973, 1998, XP000915664
Download PDF: